Badrul Alam Bony

Dr. Badrul Alam Bony

Biological Systems Engineering University of Nebraska Lincoln
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
KKKrishna Kattel
Krishna Kattel
JPJa Young Park
Ja Young Park
WXWenlong Xu
Wenlong Xu
HKHan Gyeol Kim
Han Gyeol Kim
ELEun Jung Lee
Eun Jung Lee
Gang Ho LeeGang Ho Lee
Gang Ho Lee

1 April 2012 in Biomaterials
Verified
Journal Article
Closed access
KKKrishna Kattel
Krishna Kattel
JPJa Young Park
Ja Young Park
WXWenlong Xu
Wenlong Xu
HKHan Gyeol Kim
Han Gyeol Kim
ELEun Jung Lee
Eun Jung Lee
GLGang Ho Lee
Gang Ho Lee

13 November 2013 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WXWenlong Xu
Wenlong Xu
BBBadrul Alam Bony
Badrul Alam Bony
CKCho Rong Kim
Cho Rong Kim
JBJong Su Baeck
Jong Su Baeck
YCYongmin Chang
Yongmin Chang
Gang Ho LeeGang Ho Lee
Gang Ho Lee
There is no doubt that the molecular imaging is an extremely important technique in diagnosing diseases. Dual imaging is emerging as a step forward in molecular imaging technique because it can provide us with more information useful for diagnosing diseases than single imaging. Therefore, diverse dual imaging modalities should be developed. Molecular imaging generally relies on imaging agents. Mixed lanthanide oxide nanoparticles could be valuable materials for dual magnetic resonance imaging (MRI)-fluorescent imaging (FI) because they have both excellent and diverse magnetic and fluorescent properties useful for dual MRI-FI, depending on lanthanide ions used. Since they are mixed nanoparticles, they are compact, robust, and stable, which is extremely useful for biomedical applications. They can be also easily synthesized with facile composition control. In this study, we explored three systems of ultrasmall mixed lanthanide (Dy/Eu, Ho/Eu, and Ho/Tb) oxide nanoparticles to demonstrate their usefulness as dual T2 MRI–FI agents.

11 September 2012 in RSC Advances
Verified
Journal Article
Closed access
PDF file
WXWenlong Xu
Wenlong Xu
JPJa Young Park
Ja Young Park
KKKrishna Kattel
Krishna Kattel
Md Wasi AhmadMd Wasi Ahmad
Md Wasi Ahmad
BBBadrul Alam Bony
Badrul Alam Bony
Gang Ho LeeGang Ho Lee
Gang Ho Lee
We report the synthesis, characterization and application of highly water-soluble fluorescein-polyethyleneimine (PEI) coated gadolinium oxide (Gd2O3) nanoparticles to magnetic resonance imaging (MRI) and cell labeling (CL). The average particle diameter and average hydrodynamic diameter were estimated to be 3.92 and 7.5 nm, respectively. Fluorescein-PEI was prepared from EDC/NHS coupling method. The surface coating was characterized by the FT-IR absorption spectrum and the surface coating amount was estimated to be 22.42 wt% from a TGA analysis, corresponding to 0.65 nm−2 grafting density. The fluorescein-PEI coated gadolinium oxide nanoparticles showed r1 and r2 of 6.76 and 20.27 s−1mM−1, respectively, and a strong fluorescence at ∼527 nm. A pronounced positive contrast enhancement was clearly observed in 3 tesla T1 MR images of a rat with a liver tumor after injection of an aqueous sample solution into a rat tail vein. After treatment of DU145 cells with a sample solution, a strong fluorescence in confocal images was also observed. These two results together confirm the excellent MRI-CL dual functionality of fluorescein-PEI coated gadolinium oxide nanoparticles.

13 September 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
BBBadrul Alam Bony
Badrul Alam Bony
FKForrest M Kievit
Forrest M Kievit
Traumatic brain injury (TBI) is one of the main causes of disability in children and young adults, as well as a significant concern for elderly individuals. Depending on the severity, TBI can have a long-term impact on the quality of life for survivors of all ages. The primary brain injury can result in severe disability or fatality, and secondary brain damage can increase the complexities in cellular, inflammatory, neurochemical, and metabolic changes in the brain, which can last decades post-injury. Thus, survival from a TBI is often accompanied by lifelong disabilities. Despite the significant morbidity, mortality, and economic loss, there are still no effective treatment options demonstrating an improved outcome in a large multi-center Phase III trial, which can be partially attributed to poor target engagement of delivered therapeutics. Thus, there is a significant unmet need to develop more effective delivery strategies to overcome the biological barriers that would otherwise inhibit transport of materials into the brain to prevent the secondary long-term damage associated with TBI. The complex pathology of TBI involving the blood-brain barrier (BBB) has limited the development of effective therapeutics and diagnostics. Therefore, it is of great importance to develop novel strategies to target the BBB. The leaky BBB caused by a TBI may provide opportunities for therapeutic delivery via nanoparticles (NP). The focus of this review is to provide a survey of NP-based strategies employed in preclinical models of TBI and to provide insights for improved NP based diagnostic or treatment approaches. Both passive and active delivery of various NPs for TBI are discussed. Finally, potential therapeutic targets where improved NP-mediated delivery could increase target engagement are identified with the overall goal of providing insight into open opportunities for NP researchers to begin research in TBI.

8 November 2021 in ACS Nano
Verified
Journal Article
Closed access
BBBadrul Alam Bony
Badrul Alam Bony
ATAria W. Tarudji
Aria W. Tarudji
HMHunter A. Miller
Hunter A. Miller
SGSaiprasad Gowrikumar
Saiprasad Gowrikumar
SRSourav Roy
Sourav Roy
FKForrest M Kievit
Forrest M Kievit